Logo der Deutsch Industrie- und Handelskammer in Japan

German Regenerative Medicine Networking Reception

  • Event

7 October 2026 | Short Company Pitches & Networking Buffet | InterContinental Yokohama Grand

AdobeStock_404759838 1.jpeg
Meet Berlin’s Life Sciences Innovators in Yokohama 

 

On the opening evening of BioJapan 2026, Berlin Partner for Business and Technology and the German Chamber of Commerce and Industry in Japan (AHK Japan) invite representatives of Japan’s life sciences community to meet a high-level delegation from Berlin. 

 

Berlin-Brandenburg is home to a highly connected life sciences ecosystem comprising more than 760 companies, start-ups, research institutions and other stakeholders. The visiting delegation brings together innovative biotechnology companies, translational research institutions, technology providers and public-sector representatives active in personalized and regenerative medicine, cell and gene therapy, ATMP development, immunological biomarkers, precision immunotherapy, biologics development, drug discovery, digital health and data-driven R&D. 

 

During a series of concise pitches, the participating organizations will introduce their technologies, capabilities and cooperation interests. A networking buffet will then provide ample time for direct exchanges and individual discussions with the German delegates. 

If you participate and/or exhibit at Bio-Japan and would like to meet one of our german participating companies for an individual B2B meeting, please feel free to directly contact: bhaverland@dihkj.or.jp (Englisch or Japanese).  

 

The event is designed to initiate concrete cooperation in areas such as: 

 

• Joint research and development 

• Licensing and co-development 

• Clinical and contract research 

• Technology validation and transfer 

• Investment and strategic partnerships 

 

Representatives of Japanese pharmaceutical and biotechnology companies, CROs and CDMOs, universities, hospitals, research institutions, investors, industry associations, clusters and other relevant organizations are warmly invited to attend.

  • Participation Costs

    Free of charge | Prior registration and confirmation by the organisers are required | The networking buffet is included.

  • Wednesday 7 October 2026

    17:00–20:00 JST | Reception and registration open at 16:30.

Programme

Preliminary Programme 

  • 16:30: Reception and registration
  • 17:00: Opening remarks
  • 17:10: Introduction to Berlin’s life sciences ecosystem and the Berlin goes Japan delegation
  • 17:20: Short pitches by participating companies and institutions
  • 18:20: Networking buffet and individual business discussions
  • 19:55: Closing remarks 

The program and participating organisations are subject to change. 

 

This is an independently organised side event and is not part of the official BioJapan program. Registration for this event does not include admission to BioJapan or access to the BioJapan partnering system. 

 

IMPORTANT NOTES AND CONDITIONS FOR PARTICIPATION

• Registrations will be reviewed and confirmed individually by the organisers. 

• Registration will close once the maximum venue capacity has been reached. 

• To ensure relevant and productive discussions, the organisers may prioritize applicants whose professional backgrounds and cooperation interests are closely related to the event. 

• Please bring at least two business cards to facilitate registration and networking. 

• Participants who are no longer able to attend are kindly requested to notify the organisers as early as possible. 

• The program, speakers and participating organisations may be changed for organisational reasons. 

• Registration includes participation at the networking buffet 
 

PARTICIPATING ORGANISATIONS AND COMPANIES

The Following companies will introduce themselves on stage and will be available for you during the networking session. 

Note: If you participate and/or exhibit at Bio-Japan and would like to meet one of our German participating companies for an individual B2B meeting, please feel free to directly contact: bhaverland@dihkj.or.jp (Englisch or Japanese).  

PUBLIC SECTOR, RESEARCH AND LIFE SCIENCES ECOSYSTEM 
Senate Department for Economic Affairs, Energy and Public Enterprises of the State of Berlin The Senate Department for Economic Affairs, Energy and Public Enterprises supports the development and international competitiveness of Berlin’s economy and innovation landscape. The delegation is represented by the department responsible for the healthcare industry, providing a direct public-sector perspective on Berlin’s life sciences strategy and international cooperation. 
BIH at Charité – BIH Center for Regenerative Therapies The BIH Center for Regenerative Therapies at Charité is an interdisciplinary translational research center investigating the body’s own healing processes and developing new therapies and diagnostic tools. Its work connects clinical disciplines, advanced technology platforms and personalized approaches across regenerative medicine, cell and gene therapy, biomaterials and clinical translation. The advantages for operators of biogas plants are above all the improved fermentation, in particular feeding difficult substrates, with an increase of the biogas yield and / or saving of the substrate. Additional income or savings of 8 to 15% are achieved. In addition reducing viscosity helps optimize plant operation.
Campus Berlin-Buch GmbH Campus Berlin-Buch is a leading biomedical science, health and biotechnology location combining internationally recognized research institutions, clinical expertise and one of Germany’s largest biotechnology parks. Campus Berlin-Buch GmbH develops the site, supports resident companies and fosters technology transfer, scientific collaboration and the growth of life sciences ventures. 
BIOTECHNOLOGY, REGENERATIVE MEDICINE AND DRUG DEVELOPMENT 
CheckImmune GmbH CheckImmune is a Charité spin-off and specialist provider of immunological biomarker services for drug development. The company combines biomarker consulting, advanced laboratory analyses and scientific and medical data interpretation to support small molecules, biologics and advanced therapy medicinal product programs in accredited, GCLP-compliant laboratories. 
Nuvisan ICB GmbH Nuvisan ICB is Nuvisan’s Berlin-based Innovation Campus and part of an integrated CRO/CDMO supporting pharmaceutical and biotechnology programs from target to patient. Its capabilities cover target identification, omics and biomarkers, screening, medicinal chemistry, pharmacology, translational research, preclinical and clinical development, CMC and data science. 
Alithea Biotechnology GmbH Alithea Biotechnology develops data-driven solutions for precision immunotherapy. By combining immunopeptidomics, high-sensitivity mass spectrometry, bioinformatics and artificial intelligence, the company supports HLA-peptide characterization, target and neoantigen discovery, TCR-therapy development and the early assessment of potential off-target risks. 
Pheiron GmbH Pheiron is an AI-native biotechnology company developing causal models based on primary human data to improve biological target selection and patient stratification. Its approach is designed to support earlier, evidence-based decisions in drug development, reduce clinical failure risk and increase research and development productivity. 
FyoniBio GmbH FyoniBio is a biopharmaceutical development partner supporting biologics from early research to clinical development. Its services include cell-line and process development, bioanalytical and CMC characterization, mass-spectrometry analytics, functional and potency assays, and GCLP-compliant clinical bioanalysis. 
MyoPax GmbH MyoPax develops regenerative cell and gene therapies for severe muscle diseases. Its proprietary platform combines muscle stem-cell manufacturing with cell engineering and gene-editing technologies, with the goal of restoring muscle function in local defects, hereditary muscular dystrophies and other muscle-wasting disorders. 
INNOVATION, DIGITAL HEALTH AND DATA-DRIVEN LIFE SCIENCES 
innos GmbH innos is an innovation and technology management consultancy that helps companies, clusters and public-sector stakeholders turn emerging technologies into viable strategies, networks and collaborative projects. Its expertise includes innovation strategy, technology management, network and cluster development, and cross-sector cooperation in fields including life sciences and biotechnology. 
NEUROLONICS NEUROLONICS develops AI-supported digital tools for emotional monitoring and mental-wellness support. Its platform combines self-assessment, longitudinal emotion tracking and conversational features, with potential applications in healthcare, education and workplace settings. 
Leap Dynamics GmbH Leap Dynamics builds auditable artificial intelligence, data-science and software systems for regulated organizations. For pharmaceutical, CRO and life sciences teams, the company develops reproducible R and Python workflows, clinical-data automation, bioinformatics solutions, validated reporting pipelines, dashboards and traceable analytics. 

ORGANISERS

Berlin Partner for Business and Technology GmbH

 

German Chamber of Commerce and Industry in Japan – AHK Japan

AHK Japan is the key institution of Germany’s foreign trade promotion in Japan. It supports German and Japanese companies through market-entry services, business matching, delegation management, event organization and bilateral business networks. 

Registration Form

To register for the event, please use the online form displayed below. This form is generated by SuperOffice (online.superoffice.com). If the form is not displayed, please change your privacy settings. This form is not available in Internet Explorer.

Disclaimer ©2026 German Chamber of Commerce and Industry in Japan (AHK Japan). No part of this presentation may be reproduced without prior permission. While every reasonable effort is made to ensure that the information provided is accurate, no guarantees for the currency or accuracy of information are made. All material relating to information, products and services (or to third party information, products and services), is provided 'as is', without any representation or endorsement made and without warranty of any kind, including the implied warranties of satisfactory quality, fitness for a particular purpose, non-infringement, compatibility, security and accuracy. The speakers are solely responsible for the content thereof; In no event will the organizer and/or the speakers be liable for any loss or damage whatsoever arising from infringement or any defect of rights of the content of the presentation. Views expressed are not necessarily those of AHK Japan. All our events follow Chatham House Rules.

Ansprechpartner

In den Kategorien:

Die neuesten Veranstaltungen ansehen

Alle Veranstaltungen ansehen
  • flyer
    Veranstaltung

    Tennis Gathering & BBQ Dinner 2026

    26 September 2026 | Joint Chamber | Yokohama Country & Athletic Club

  • European Cocktail Banner with logos 12 chambers.png
    Veranstaltung

    European Cocktail 2026

    October 19th, 2026 | Joint Chamber | Members only

Suchen Sie etwas Anderes?

In unserem Informationszentrum finden Sie aktuelle Neuigkeiten, Downloads, Videos, Podcasts...

Zum Info Hub